This is a complete copy of the IAOMT's addendum to their Petition for Reconsideration submitted by Jim Love, et al in March of 2013. The addendum to the petition added new proof of the damaging effect of mercury in amalgams and asked that mercury in dental materials either be banned or reclassified as an FDA Class III device thus restricting its use and increasing regulations when using this product.
Michael Fleming DDS examines the role of the FDA concerning amalgam's use in dentistry. He also discusses common misconceptions and breaks down the arguments about amalgam's safety to their core components and examines them individually.
G. Mark Richardson examines the various exposures to mercury from amalgam versus that of the recommended amount of tuna fish (EPA) and compares them to reference exposure levels to find out which presents more of a risk to human health.
Resin-based composites have a number of advantages for restorative treatment. They possess desirable aesthetic properties and favor retention of sound tooth structure because they require less cavity preparation than traditional amalgam restorations. Recent clinical studies have demonstrated that composites can now match or exceed the longevity of amalgam.
A European Commission study recommends phasing out dental amalgam use in the next five years. The BIOS report noted that mercury-free fillings appear more expensive than amalgam because the negative external costs associated with management of amalgam waste and effluents are not factored into the market price.
The Norwegian Climate and Pollution Agency (Klif) sponsored a review of the experiences from the phase-out of the use of dental amalgam as tooth filling material in Norway, and to make an assessment of the costs to the society from the actions taken to limit the release of mercury. The purpose was to show how Norway has carried out this policy.
Mercury fillings are more expensive than the mercury-free alternatives, according to a new study released by a broad coalition of health, consumer, and environmental groups. The study details how society pays for dental mercury through additional pollution control costs, deterioration of public resources, and the health effects associated with mercury contamination.
When covering the 2010 FDA dental products panel hearing on the safety of dental amalgam fillings, the press widely promoted the "red herring" comment from FDA panelist, Susan Griffin (of the EPA). The comment was directed at the assertion that the Fawer study should not be relied on for the basis of a risk assessment because many of the workers in the study were also exposed to chlorine, which inhibits uptake of mercury (up to 40%).
Mercuryexposure.info was created and is maintained by consumers injured from exposure to mercury vapor and particles released by their dental amalgam fillings during placement, polishing, removal and day to day use. We are dedicated to providing accurate, up to date information on the many facets of dental mercury amalgam fillings.